MedTrace Logo

Exploration of Cluster Headache in a PET-MRI Study

NCT05084469 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2021-10-19

No results posted yet for this study

Summary

Observational study in PET-MRI using the 5-HT1A agonist PET radiotracer \[18F\]F13640.

Conditions

  • Cluster Headache, Episodic

Interventions

PROCEDURE

PET-MRI in pain-free remission period

Patients will performed PET-MRI scans. A first 30 minutes acquisition will be performed at time=60min after injection. A second 75 minutes acquisition will be performed at time=150min. Each scans will contain functional dynamic \[18F\]F13640 PET acquisition, anatomical and functional MRI images acquisition and pain evaluation using a score visual analogic scale.

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Principal Investigators

  • Genevieve Demarquay, MD · Centre d'évaluation et traitement de la douleur

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2024-02-01
Completion
2024-02-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05084469 on ClinicalTrials.gov